Treatment of Acne Vulgaris and Prevention of Acne Scarring: Canadian Consensus Guidelines

Abstract

Get full access to this article

View all access options for this article.

References

. Acne management for the 90s: Current treatment guidelines. Can J Diagnosis 1995; (Suppl):5–25.

Livneh

. On the origins of negative attitudes toward people with disabilities. Rehab Lit 1982; 43:338–347.

Van der Meeren

HLM

van der Schaar

van den Hurk

MAM

. The psychological impact of severe acne. Cutis 1985; 36:84–86.

Schuster

Fisher

Harris

. The effect of skin disease on self image. Br J Dermatol 1978; 99(Suppl 16):18–19.

Kellett

Gawkrodger

. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol 1999; 140:273–282.

Gupta

. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139:846–850.

Layton

. Acne scarring—reviewing the need for the early treatment of acne. J Dermatol Treat 2000; 11:3–6.

Jowett

Ryan

. Skin disease and handicap. An analysis of the impact of skin conditions. Soc Sci Med 1985; 20:425–429.

Cunliffe

. Acne and unemployment. Br J Dermatol 1986; 115:386.

10.

Sulzberger

Zaidens

. Psychogenic factors in dermatologic disorder. Med Clin North Am 1948; 32:669–672.

11.

Layton

Henderson

Cunliffe

. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol 1994; 19:303–308.

12.

Cunliffe

Layton

. Oral isotretinoin: Patient selection and management. J Dermatol Treat 1993; 4(Suppl 2):S10–S15.

13.

Cunliffe

Simpson

. Disorders of the subaceous glands. In: Champion

Wilkinson

Ebling

FJC

, eds. Textbook of dermatology. 6th Ed. Maiden, PA: Blackwell Science, 1998:1964–1970.

14.

Leyden

. Therapy for acne vulgaris. N Engl J Med 1997; 336:1156–1162.

15.

Harms

Masouyé

Radeff

. The relapses of cystic acne after isotretinoin treatment are age related: A long-term follow-up study. Dermatologica 1986; 172:148–153.

16.

Layton

Stainforth

Cunliffe

. Ten years' experience of oral isotretinoin for the treatment of acne vulgaris. J Dermatol Treat 1993; 4(Suppl 2):S2–S5.

17.

White

. Recurrence rates after the first course of isotretinoin. Arch Dermatol 1998; 134:376–378.

18.

King

Jones

Daltrey

Cunliffe

. A double-blind study of the effects of 13-cis retinoic acid on acne, sebum excretion rate and microbial population. Br J Dermatol 1982; 107:583–590.

19.

Dalziel

Barton

Marks

. The effects of isotretinoin on follicular and sebaceous gland differentiation. Br J Dermatol 1987; 117:317–323.

20.

Leyden

McGinley

. Effect of 13-cis retinoic acid on sebum production and Propionibacterium acnes in severe nodulocystic acne. Arch Dermatol Res 1982; 272:331–337.

21.

Falcon

Lee

Shalita

. In vitro effect of isotretinoin on monocyte Chemotaxis. J Invest Dermatol 1986; 86:550–552.

22.

Cunliffe

van de Kerkhof

PCM

Caputo

. Accutane treatment guidelines: Results of an international survey. Dermatology 1997; 194:351–357.

23.

Accutane product monograph. Hoffmann-La Roche Ltd., Mississauga, Ontario, Canada, 1998.

24.

Isotretinoin package insert. Hoffman-La Roche Ltd.

25.

Maddin

. Current dermatologic therapy II. 2nd Ed. Philadelphia: WB Saunders, 1991.

26.

Clark

Cunliffe

. Acne flare and isotretinoin—incidence and treatment. Br J Dermatol 1995; 113(Suppl 45):26.

27.

Willoughby

Rosenthal

. Monitoring isotretinoin therapy in acne: Rational use of laboratory tests. J Cutan Med Surg 1997; 2:72–77.

28.

Barth

Macdonald-Hull

Mark

. Isotretinoin therapy for acne vulgaris: A re-evaluation of the need for measurements of plasma lipids and liver function tests. Br J Dermatol 1993; 129:704–707.

29.

Marsden

. Lipid metabolis and retinoid therapy. Pharmacol Ther 1989; 40:55–65.

30.

Ragos

Houlden

Danby

. Effect of isotretinoin therapy on serum total cholesterol and triglycerides. Can J Clin Pharmacol 1998; 5:43–47.

31.

Searles

Ooi

. Underrecognition of chylomicronemia as a cause of acute pancreatitis. Can Med Assoc J 1992; 147:1806–1808.

32.

Zimmerman

. Drug and toxin-induced liver disease. In: Stein

, ed. Internal medicine. 5th Ed. St. Louis, MO: Mosby, 1998.

33.

Simpson

. Social and economic aspects of acne and the cost-effectiveness of isotretinoin. J Dermatol Treat 1993; 4(Suppl 2):S6–S9.

34.

Wessels

Anderson

Kropman

. The cost-effectiveness of isotretinoin in the treatment of acne. S Afr Med J 1999; 89:780–794.

35.

Solish

Ramen

Pollack

. Approaches to acne scarring: A review. J Cutan Med Surg 1998; 2(Suppl 3):24–32.

36.

Cunliffe

. Chapter 19; Treatment of acne scars. In: Acne, 1989; 337–353. London, England: Martin Dunitz Ltd.

37.

Greenwood

Jones

Brommitt

. Comparison of isotretinoin and cyproterone acetate—a clinical and laboratory study. In: Cunliffe

Miller

, eds. Retinoid therapy Lancaster, UK: MTP Press, 1984:287–292.

38.

Cunliffe

. The management of acne. Schering Dermatology.

39.

Patterson

Peeden

Sirlin

. Morbidity and mortality weekly report: Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin. JAMA 2000; 283:471.

40.

Coates

Adams

Cunliffe

. Does oral isotretinion prevent P. acnes resistance? Dermatology 1997; 195(Suppl l):4–9.

41.

Jurzyk

Spielvogel

Rose

. Antiandrogens in the treatment of acne and hirsutism. Am Fam Phys 1992; 45:1803–1806.

42.

Beswick

Direkze

Groves

. The pros and cons of Dianette treatment. Retinoids 1997; 13:82–84.

43.

Greenwood

Brummitt

Burke

Cunliffe

. Acne: Double-blind clinical and laboratory trial of tetracycline, oestrogen-cyproterone acetate, and combined treatment. BMJ 1985; 291:1231–1235.

44.

Monk

Almeyda

Caldwell

. Efficacy of low-dose cyproterone acetate compared with minocycline in the treatment of acne vulgaris. Clin Exp Dermatol 1987; 12:319–322.

45.

Hansted

Reymann

. Cyproterone acetate in the treatment of acne vulgaris in adult females. Dermatologica 1982; 164:117–126.

46.

Erkkola

Hirvonen

Luikku

. Ovulation inhibitors containing cytproterone acetate or desogestrel in the treatment of hyperandrogenic symptoms. Acta Obstet Gynecol Scand 1990; 69:61–65.

47.

Diane-35 product monograph. Berlex Canada Inc., Lachine, Canada, 1998.

48.

Carlborg

. Cyproterone acetate versus levonorgestrel combined with ethinyl estradiol in the treatment of acne. Acta Obstet Gynecol Scand 1986; (Suppl)134:29–32.

49.

Aydinlik

. From Diane to Diane-35. In: Breckwaldt

, ed. Diagnosis and therapy of androgenization, 1992; 75–76. Berlin, Germany: Diesbag Verlag.

50.

Aydinlik

Lachnit-Fixson

Lehnert

. Oestrogen-reduced ovulation inhibitors for the treatment of acne. A double-blind comparative study of Diane-35 and Diane. Fortschr Med 1986; 104:3–10.

51.

Colver

Mortimer

Dawber

RPR

. Cyproterone acetate and two doses of oestrogen in female acne; a double-blind comparison. Br J Dermatol 1988; 118:95–99.

52.

Shaw

Susumu

Ayako

Itsuro

. Three cases of hepatocellular carcinoma among cyproterone users. Lancet 1994; 344:1567–1568.

53.

Heinemann

LAJ

Will-Shahab

Kesteren

. Safety of cyproterone acetate: Report of active surveillance. Pharmacoepidemiol Drug Saf 1997; 6:169–178.